Kyowa Kirin, INC
Pharmaceutical company
Based in NJ
🤖
AI Overview
With $460K in lobbying spend across 4 quarterly filings, Kyowa Kirin, INC is an active lobbying client. Their lobbying covers 2 issue areas.
$460K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $460K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Trade
- •FDA modernization policy issues General issues related to rare disease and clinical trials General issues related to diagnostics for patients with rare diseases Issues related to drug pricing Issues r
- •FDA modernization policy issues. General issues related to rare disease and clinical trials. General issues related to diagnostics for patients with rare diseases. Issues related to drug pricing. Issu
- •Issues related to trade.
- •Trade/tariffs and pharmaceutical pricing/value
- •Tariffs and trade policy
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.